Faculty of Science, University of British Columbia, Vancouver, BC, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Subst Use Misuse. 2020;55(10):1692-1701. doi: 10.1080/10826084.2020.1756854. Epub 2020 May 14.
Methamphetamine (MA) use among gay, bisexual, and other men who have sex with men (gbMSM) is a pervasive issue, associated with detrimental health outcomes. We identified factors associated with discontinuation or reduction in MA among a subset of gbMSM reporting frequent (at least weekly) use, with a specific focus on symptoms of anxiety and depression. We recruited sexually-active gbMSM aged ≥16 years in Vancouver, Canada into a prospective-cohort study using respondent-driven sampling. Participants completed study visits once every six months. We used generalized linear mixed models to identify factors associated with reductions in MA use following a visit where participants previously reported using MA at least weekly. Of 584 cohort participants with at least one follow-up visit, 67 (11.5%) reported frequent MA use at baseline or in follow-up visits. Of these, 46 (68.7%) had at least one subsequent study visit where they transitioned to less frequent (monthly or less) or no MA use. In multivariable models, reduced MA use was less likely for those who spent >50% of social time with other gbMSM (aRR = 0.49, 95%CI:0.28-0.85), gave or received drugs in exchange for sex (aRR = 0.34, 95%CI:0.13-0.87), injected drugs (aRR = 0.35, 95%CI:0.18-0.68), or used gamma-hydroxybutyrate (GHB) (aRR = 0.41, 95%CI:0.21-0.78). Symptoms of anxiety or depression were not associated with reductions in MA use. Social connection and drug-related factors surrounding MA use were associated with reductions, but anxiety and depressive symptomatology were not. Incorporating socialization and polysubstance-related components with MA reduction may help in developing efficacious interventions toward reducing MA use for gbMSM.
甲基苯丙胺(MA)在男同性恋、双性恋和其他与男性发生性关系的男性(gbMSM)中的使用是一个普遍存在的问题,与不良健康结果有关。我们确定了与一组报告频繁(至少每周一次)使用 MA 的 gbMSM 中停止或减少 MA 使用相关的因素,特别关注焦虑和抑郁症状。我们使用响应驱动抽样在加拿大温哥华招募了年龄在 16 岁及以上的活跃 gbMSM 进入前瞻性队列研究。参与者每六个月完成一次研究访问。我们使用广义线性混合模型来确定在参与者之前报告每周至少使用一次 MA 的访问后减少 MA 使用的相关因素。在至少有一次随访访问的 584 名队列参与者中,有 67 名(11.5%)在基线或随访访问中报告频繁使用 MA。其中,有 46 名(68.7%)至少有一次后续研究访问,他们过渡到较少使用(每月或更少)或不使用 MA。在多变量模型中,与其他 gbMSM 共度的社交时间超过 50%(ARR = 0.49,95%CI:0.28-0.85)、用药物换取性(ARR = 0.34,95%CI:0.13-0.87)、注射药物(ARR = 0.35,95%CI:0.18-0.68)或使用γ-羟基丁酸(GHB)(ARR = 0.41,95%CI:0.21-0.78)的人不太可能减少 MA 的使用。焦虑或抑郁症状与减少 MA 使用无关。围绕 MA 使用的社交和药物相关因素与减少有关,但焦虑和抑郁症状无关。将社交和多物质相关因素与 MA 减少结合起来,可能有助于为 gbMSM 开发有效的减少 MA 使用干预措施。